Effects of loratadine, a histamine H1 receptor antagonist, on the skeletal system of young male rats

Drug Des Devel Ther. 2019 Sep 23:13:3357-3367. doi: 10.2147/DDDT.S215337. eCollection 2019.

Abstract

Background: Histamine H1 receptor antagonists are widely used in the treatment of allergic diseases. H1 receptors are expressed on bone cells and histamine takes part in regulation of bone metabolism. Loratadine is often prescribed to children.

Purpose: The aim of the present study was to investigate the effects of loratadine on the skeletal system of young rats.

Material and methods: Loratadine (0.5, 5, and 50 mg/kg p.o. daily) was administered for 4 weeks to male Wistar rats, 6-week-old at the start of the experiment. Bone mass, mass of bone mineral, calcium, and phosphorus content in the bone mineral of the tibia, femur, and L-4 vertebra, histomorphometric parameters of the femur, mechanical properties of the proximal tibial metaphysis, femoral diaphysis and femoral neck, and serum levels of bone turnover markers were examined.

Results: Loratadine at 0.5 and 5 mg/kg did not significantly affect the skeletal system of young rats. At 50 mg/kg, loratadine decreased the femoral length, increased content of calcium and phosphorus in the bone mineral of the vertebra, and tended to improve mechanical properties of the tibial metaphysis.

Conclusion: High-dose loratadine slightly but significantly affected development of the skeletal system in rapidly growing rats.

Keywords: bone; histamine H1 receptor antagonists; loratadine; rats.

MeSH terms

  • Animals
  • Bone and Bones / drug effects*
  • Bone and Bones / metabolism
  • Histamine H1 Antagonists / pharmacology*
  • Loratadine / pharmacology*
  • Male
  • Musculoskeletal System / drug effects*
  • Musculoskeletal System / metabolism
  • Rats
  • Rats, Wistar

Substances

  • Histamine H1 Antagonists
  • Loratadine